Timo L M Ten Hagen - JoVE Visualize

Showing results (61-70 of 160) with videos related to

Pageof 16

Sort By:

Surgery|January 21, 2014

Exposing endothelial cells to tumor necrosis factor-α and peripheral blood mononuclear cells damage endothelial integrity via interleukin-1ß by degradation of vascular endothelial-cadherinAnn L B Seynhaeve, Joost A P Rens, Debby Schipper, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|May 23, 2015

Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancerSara Zalba, Ana M Contreras, Azadeh Haeri, et al.

Anti-Cancer Drugs|June 3, 2005

Addition of low-dose tumor necrosis factor-alpha to systemic treatment with STEALTH liposomal doxorubicin (Doxil) improved anti-tumor activity in osteosarcoma-bearing ratsSaske Hoving, Ann L B Seynhaeve, Sandra T van Tiel, et al.

Pharmacological Research|March 17, 2023

HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy responseMehrdad Hashemi, Mohsen Rashidi, Kiavash Hushmandi, et al.

Breast Cancer Research and Treatment|October 12, 2012

E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cellsRemco van Horssen, Antoinette Hollestelle, Joost A P Rens, et al.

International Journal of Cancer|January 5, 2002

Pegylated liposomal tumor necrosis factor-alpha results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil) in soft tissue sarcoma-bearing ratsTimo L M ten Hagen, Ann L B Seynhaeve, Sandra T van Tiel, et al.

Communications Biology|July 29, 2021

Drug transport kinetics of intravascular triggered drug delivery systemsTimo L M Ten Hagen, Matthew R Dreher, Sara Zalba, et al.

Advances in Colloid and Interface Science|February 25, 2020

Potential application of liposomal nanodevices for non-cancer diseases: an update on design, characterization and biopharmaceutical evaluationFereshteh Bayat, Reza Hosseinpour-Moghadam, Fatemeh Mehryab, et al.

Pharmaceutical Research|November 1, 2015

Pharmacokinetics, Tissue Distribution and Therapeutic Effect of Cationic Thermosensitive Liposomal Doxorubicin Upon Mild HyperthermiaBilyana M Dicheva, Ann L B Seynhaeve, Thomas Soulie, et al.

Pharmaceutical Research|July 24, 2015

Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive LiposomesBilyana M Dicheva, Timo L M ten Hagen, Ann L B Seynhaeve, et al.

Pageof 16

Showing results (61-70 of 160) with videos related to

Sort By:

Pageof 16

Surgery|January 21, 2014

Exposing endothelial cells to tumor necrosis factor-α and peripheral blood mononuclear cells damage endothelial integrity via interleukin-1ß by degradation of vascular endothelial-cadherinAnn L B Seynhaeve, Joost A P Rens, Debby Schipper, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|May 23, 2015

Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancerSara Zalba, Ana M Contreras, Azadeh Haeri, et al.

Anti-Cancer Drugs|June 3, 2005

Addition of low-dose tumor necrosis factor-alpha to systemic treatment with STEALTH liposomal doxorubicin (Doxil) improved anti-tumor activity in osteosarcoma-bearing ratsSaske Hoving, Ann L B Seynhaeve, Sandra T van Tiel, et al.

Pharmacological Research|March 17, 2023

HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy responseMehrdad Hashemi, Mohsen Rashidi, Kiavash Hushmandi, et al.

Breast Cancer Research and Treatment|October 12, 2012

E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cellsRemco van Horssen, Antoinette Hollestelle, Joost A P Rens, et al.

International Journal of Cancer|January 5, 2002

Pegylated liposomal tumor necrosis factor-alpha results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil) in soft tissue sarcoma-bearing ratsTimo L M ten Hagen, Ann L B Seynhaeve, Sandra T van Tiel, et al.

Communications Biology|July 29, 2021

Drug transport kinetics of intravascular triggered drug delivery systemsTimo L M Ten Hagen, Matthew R Dreher, Sara Zalba, et al.

Advances in Colloid and Interface Science|February 25, 2020

Potential application of liposomal nanodevices for non-cancer diseases: an update on design, characterization and biopharmaceutical evaluationFereshteh Bayat, Reza Hosseinpour-Moghadam, Fatemeh Mehryab, et al.

Pharmaceutical Research|November 1, 2015

Pharmacokinetics, Tissue Distribution and Therapeutic Effect of Cationic Thermosensitive Liposomal Doxorubicin Upon Mild HyperthermiaBilyana M Dicheva, Ann L B Seynhaeve, Thomas Soulie, et al.

Pharmaceutical Research|July 24, 2015

Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive LiposomesBilyana M Dicheva, Timo L M ten Hagen, Ann L B Seynhaeve, et al.

Pageof 16